April 5, 2011 |
An antibiotic developed by a San Diego firm received a government panel's backing as a treatment for diarrhea caused by increasingly common bacterial infections often acquired in hospitals and nursing homes. The panel of outside experts convened by the Food and Drug Administration voted 13 to 0 that fidaxomicin, marketed under the trade name Dificid by Optimer Pharmaceuticals Inc., is safe and effective in combating symptoms associated with Clostridium difficile , also known as C. diff . The unanimous vote endorsed the FDA's preliminary findings and increases the chances that the agency will approve fidaxomicin.
March 22, 2011 |
For most of us living in the developed world, diarrhea is an uncomfortable nuisance -- not a life-threatening event. But each year for more than a million children under the age of 5, it is a killer. It's known that a few simple precautions and treatments can make a difference and save a child. What's been unknown, say researchers led by Christa Fischer Walker of the Johns Hopkins School of Public Health, is whether providing those interventions makes a difference on a large scale, cutting disease and death rates around the globe.
June 15, 2009 |
For an abscessed tooth, I was given an antibiotic called clindamycin. Ever since I took it, I have had unremitting diarrhea. My dentist wants me to see a gastroenterologist. Please make an appointment with a gastroenterologist immediately. Clindamycin can trigger dangerous diarrhea by allowing bad bacteria called Clostridium difficile (C. diff) to flourish. We don't want to worry you, but this condition could be lethal if left untreated.
June 6, 2006 |
In its quest to genetically engineer rice with human genes to produce a treatment for childhood diarrhea, tiny Ventria Bioscience has made an astonishing number of powerful enemies spanning the political spectrum. Environmental groups, corporate food interests and thousands of farmers across the country have succeeded in chasing the company's rice farms out of two states.
March 12, 2006 |
A week before your trip to Mexico, the express mail van drops off a small package that might just save your vacation. You open it carefully and dial the number listed on the instruction sheet. The nurse who answers gives you instructions on how to prepare, then drink the vaccine that's just been delivered. You stir it into a flavored beverage and drink it, hoping it will protect you from traveler's diarrhea. That scenario may sound like fantasy but could be closer to reality than you think.
February 22, 2006 |
A key federal advisory panel Tuesday recommended that all infants receive a vaccine against the most common form of diarrhea in children. The vaccine, called RotaTeq, has been shown to prevent life-threatening cases of diarrhea caused by the rotavirus. It is an oral vaccine, administered in three doses. The advisory panel to the national Centers for Disease Control and Prevention recommended that infants receive their first dose by 12 weeks and all three doses by 32 weeks.